IRadimed Corp (IRMD) stock
IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3037% above fair value
$82.31−1.14 (-1.37%)
Close on Nov 18, 2026Market cap $1.05BP/E 44.0Yield –
IRadimed operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
IRadimed's operating income for the twelve months ending Sep 30, 2026 was $28.86M, up 16.1% year over year. For fiscal 2025 it was $26.15M, up 19.0% from the year before. Over ten years it grew 8.5% a year on average. The highest annual figure on record is $26.15M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.15M | +19.0% |
| FY2024 | Dec 31, 2024 | $21.97M | +9.6% |
| FY2023 | Dec 31, 2023 | $20.04M | +28.2% |
| FY2022 | Dec 31, 2022 | $15.63M | +59.2% |
| FY2021 | Dec 31, 2021 | $9.82M | – |
| FY2020 | Dec 31, 2020 | -$756.09K | -108.7% |
| FY2019 | Dec 31, 2019 | $8.65M | +44.0% |
| FY2018 | Dec 31, 2018 | $6.00M | +367.2% |
| FY2017 | Dec 31, 2017 | $1.29M | -88.2% |
| FY2016 | Dec 31, 2016 | $10.92M | -5.2% |
| FY2015 | Dec 31, 2015 | $11.51M | +275.5% |
| FY2014 | Dec 31, 2014 | $3.07M | +10.0% |
| FY2013 | Dec 31, 2013 | $2.79M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $8.14M | +19.1% |
| Q2 FY2026 | Jun 30, 2026 | $6.39M | -5.8% |
| Q1 FY2026 | Mar 31, 2026 | $7.24M | +33.2% |
| Q4 FY2025 | Dec 31, 2025 | $7.09M | +22.3% |
| Q3 FY2025 | Sep 30, 2025 | $6.83M | +18.0% |
| Q2 FY2025 | Jun 30, 2025 | $6.79M | +20.6% |
| Q1 FY2025 | Mar 31, 2025 | $5.43M | +14.4% |
| Q4 FY2024 | Dec 31, 2024 | $5.80M | +12.4% |
| Q3 FY2024 | Sep 30, 2024 | $5.79M | -2.0% |
| Q2 FY2024 | Jun 30, 2024 | $5.63M | +13.4% |
| Q1 FY2024 | Mar 31, 2024 | $4.75M | +18.5% |
| Q4 FY2023 | Dec 31, 2023 | $5.16M | +21.3% |
| Q3 FY2023 | Sep 30, 2023 | $5.91M | +42.9% |
| Q2 FY2023 | Jun 30, 2023 | $4.96M | +19.1% |
| Q1 FY2023 | Mar 31, 2023 | $4.01M | +30.3% |
| Q4 FY2022 | Dec 31, 2022 | $4.25M | +36.8% |
| Q3 FY2022 | Sep 30, 2022 | $4.13M | +33.9% |
| Q2 FY2022 | Jun 30, 2022 | $4.17M | +125.9% |
| Q1 FY2022 | Mar 31, 2022 | $3.07M | +73.0% |
| Q4 FY2021 | Dec 31, 2021 | $3.11M | +377.6% |
| Q3 FY2021 | Sep 30, 2021 | $3.09M | +293.4% |
| Q2 FY2021 | Jun 30, 2021 | $1.84M | – |
| Q1 FY2021 | Mar 31, 2021 | $1.78M | +141.0% |
| Q4 FY2020 | Dec 31, 2020 | $651.03K | -70.9% |
| Q3 FY2020 | Sep 30, 2020 | $784.76K | -68.8% |
| Q2 FY2020 | Jun 30, 2020 | -$2.93M | -223.3% |
| Q1 FY2020 | Mar 31, 2020 | $737.24K | -51.3% |
| Q4 FY2019 | Dec 31, 2019 | $2.24M | +24.9% |
| Q3 FY2019 | Sep 30, 2019 | $2.52M | +73.9% |
| Q2 FY2019 | Jun 30, 2019 | $2.38M | +41.8% |
| Q1 FY2019 | Mar 31, 2019 | $1.51M | +39.2% |
| Q4 FY2018 | Dec 31, 2018 | $1.79M | +79.3% |
| Q3 FY2018 | Sep 30, 2018 | $1.45M | +638.6% |
| Q2 FY2018 | Jun 30, 2018 | $1.68M | +411.5% |
| Q1 FY2018 | Mar 31, 2018 | $1.09M | – |
| Q4 FY2017 | Dec 31, 2017 | $999.75K | -33.6% |
| Q3 FY2017 | Sep 30, 2017 | $196.06K | – |
| Q2 FY2017 | Jun 30, 2017 | $327.58K | – |
| Q1 FY2017 | Mar 31, 2017 | -$238.38K | – |
| Q4 FY2016 | Dec 31, 2016 | $1.51M | – |
See a number that looks wrong?